Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
mTCR-transduced PBLs for NY-ESO-1+ Metastatic Cancer
NCT02774291Phase 1Terminated
- Sponsor
- Albert Einstein College of Medicine
- Start
- Apr 2017
- Primary completion
- Jul 2020
- Countries
- 1
01
Overview
Phase 1, open-label trial of anti-NY-ESO-1 mTCR-transduced autologous peripheral blood lymphocytes in malignant neoplasm, sponsored by Albert Einstein College of Medicine. Started Apr 2017; status: terminated.
02
Drugs
anti-NY-ESO-1 mTCR-transduced autologous peripheral blood lymphocytes
03
Conditions
malignant neoplasm
Beyond the preview
Go deeper on NCT02774291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02774291.